InvestSMART

EBR Systems Inc (ASX: EBR) - Announcements

Current share price for EBR : $0.135 0.005 (3.57%)+

ASX company news and announcements for EBR Systems Inc (EBR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EBR Systems Inc (EBR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EBR Systems Inc (EBR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EBR Systems Inc (EBR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$114 Notification of cessation of securities - EBR 20 Oct 2026 1:26PM $0.155 $0.135 fallen by 12.90%
$114 EBR Submits TGA ARTG Application for WiSE System 20 Oct 2026 9:00AM $0.145 $0.135 fallen by 6.90%
$114 Notification regarding unquoted securities - EBR 19 Oct 2026 9:22AM $0.140 $0.135 fallen by 3.57%
$114 EBR Systems to Participate in 19th APHRS 2026 19 Oct 2026 9:06AM $0.140 $0.135 fallen by 3.57%
$114 Amended Appointment of Chief Medical Officer 16 Oct 2026 12:18PM $0.145 $0.135 fallen by 6.90%
$114 Application for quotation of securities - EBR 16 Oct 2026 10:17AM $0.145 $0.135 fallen by 6.90%
$114 Appointment of Chief Medical Officer 16 Oct 2026 9:54AM $0.140 $0.135 fallen by 3.57%
$114 Q3 2026 Commercial Update 12 Oct 2026 9:01AM $0.235 $0.135 fallen by 42.55%
$114 Completion of FDA Inspection of New Manufacturing Facility 28 Sep 2026 9:49AM $0.245 $0.135 fallen by 44.90%
$114 Upcoming Australian Investor Conferences 24 Sep 2026 11:13AM $0.260 $0.135 fallen by 48.08%
$114 Substantial Holding Notification 22 Sep 2026 4:13PM $0.265 $0.135 fallen by 49.06%
$114 CMS Finalises Increased Inpatient Reimbursement for WiSE 21 Sep 2026 9:07AM $0.260 $0.135 fallen by 48.08%
$114 EBR FDA Plan for Addressing Echo-induced Pacing Risks 16 Sep 2026 8:37AM $0.245 $0.135 fallen by 44.90%
$114 FDA Initiates Inspection of New Manufacturing Facility 15 Sep 2026 9:24AM $0.260 $0.135 fallen by 48.08%
$114 Investor Roadshow 9 Sep 2026 9:30AM $0.300 $0.135 fallen by 55%
$114 Update on FDA Review of Cybersecurity Incident 9 Sep 2026 9:26AM $0.300 $0.135 fallen by 55%
$114 New Manufacturing Facility Achieves ISO Certification 7 Sep 2026 9:20AM $0.280 $0.135 fallen by 51.79%
$114 Cleansing Notice 25 Aug 2026 11:25AM $0.290 $0.135 fallen by 53.45%
$114 Application for quotation of securities - EBR 25 Aug 2026 11:20AM $0.290 $0.135 fallen by 53.45%
$114 Form S-8 Registration Statement 25 Aug 2026 9:01AM $0.285 $0.135 fallen by 52.63%
$114 Transition of Chief Commercial Officer 21 Aug 2026 8:38AM $0.285 $0.135 fallen by 52.63%
$114 Results of Meeting 19 Aug 2026 12:50PM $0.275 $0.135 fallen by 50.91%
$114 Q2 2026 Quarterly Activity Report and Form 10-Q Submission 12 Aug 2026 8:25AM $0.285 $0.135 fallen by 52.63%
$114 EBR to Attend Canaccord 46th Annual Growth Conference 4 Aug 2026 9:09AM $0.265 $0.135 fallen by 49.06%
$114 Investor Webinar Presentation 31 Jul 2026 9:19AM $0.275 $0.135 fallen by 50.91%

1 - 25 of 512 results

Page 1 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.